Klin Farmakol Farm. 2011;25(1):28-32

Nodule of thyroid gland

Jan Čáp
2. interní klinika LF UK a FN, Hradec Králové

Using ultrasound a thyroid nodule is detectable in more than one half of women in middle age or older. Besides history and physical examination

the most important in the diagnostic workout is thyroid ultrasound with guided fine-needle aspiration cytology. Scintigraphy

is indicated in cases with hyperthyroidism only. Laboratory investigation of thyroid function (TSH level) and antithyroid antibodies is

important. Estimation of calcitonin level as tumour marker of medullary carcinoma of the thyroid is indicated for selected cases only.

Suppressive therapy with thyroxin can decrease nodule volume in about every sixth patient in expense of low TSH level. It is considered

only in young patients after thyroid autonomy has been ruled out. The majority of cases can be only followed-up; in autonomous nodules

therapy with radioiodine is indicated. Surgery remains the treatment of choice when indicated.

Keywords: nodule of thyroid gland, screening, treatment

Published: March 18, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čáp J. Nodule of thyroid gland. Klin Farmakol Farm. 2011;25(1):28-32.
Download citation

References

  1. Bartolotta TV, Midiri M, Runza G, et al. Incidentally discovered thyroid nodules: incidence, and greyscale and colour Doppler pattern in an adult population screened by real-time compound spatial sonography. Radiol Med 2006; 111: 989-998. Go to original source... Go to PubMed...
  2. Knudsen N, Bulow I, Jorgensen T, et al. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) 2000; 53: 479-485. Go to original source... Go to PubMed...
  3. Gozu HI, Bircan R, Krohn K, et al. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 2006; 155: 535-545. Go to original source... Go to PubMed...
  4. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, et al. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol 2008; 159: 623-631. Go to original source... Go to PubMed...
  5. Krohn K, Paschke R. Clinical review 133: Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 2001; 86: 3336-3345. Go to original source...
  6. Krohn K, Fuhrer D, Holzapfel HP, et al. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab 1998; 83: 130-134. Go to original source...
  7. Krohn K, Reske A, Ackermann F, et al. Ras mutations are rare in solitary cold and toxic thyroid nodules. Clin Endocrinol (Oxf) 2001; 55: 241-248. Go to original source... Go to PubMed...
  8. Krohn K, Paschke R. Somatic mutations in thyroid nodular disease. Mol Genet Metab 2002; 75: 202-208. Go to original source... Go to PubMed...
  9. Brander AE, Viikinkoski VP, Nickels JI, et al. Importance of thyroid abnormalities detected at US screening: a 5-year follow-up. Radiology 2000; 215: 801-806. Go to original source... Go to PubMed...
  10. Alexander EK, Hurwitz S, Heering JP, et al. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 2003; 138: 315-318. Go to original source... Go to PubMed...
  11. Kuma K, Matsuzuka F, Yokozawa T, et al. Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 1994; 18: 495-498; discussion 499. Go to original source... Go to PubMed...
  12. Quadbeck B, Pruellage J, Roggenbuck U, et al. Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes 2002; 110: 348-354. Go to original source... Go to PubMed...
  13. Sandrock D, Olbricht T, Emrich D, et al. Long-term followup in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 1993; 128: 51-55. Go to original source... Go to PubMed...
  14. Meysman M, Noppen M, Vincken W. Effect of posture on the flow-volume loop in two patients with euthyroid goiter. Chest 1996; 110: 1615-1618. Go to original source... Go to PubMed...
  15. Melliere D, Saada F, Etienne G, et al. Goiter with severe respiratory compromise: evaluation and treatment. Surgery 1988; 103: 367-373. Go to PubMed...
  16. Gurlek A, Usman A, Bayraktar M, et al. Horner's syndrome: recovery after surgical excision of intrarhoracic benign multinodular goiter. Endocr J 2000; 47: 643-644. Go to PubMed...
  17. Hegedus L. Thyroid ultrasound. Endocrinol Metab Clin North Am 2001; 30: 339-360, viii-ix. Go to original source... Go to PubMed...
  18. Loh KC. Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 1997; 7: 107-113. Go to original source... Go to PubMed...
  19. Refetoff S, Harrison J, Karanfilski BT, et al. Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med 1975; 292: 171-175. Go to original source... Go to PubMed...
  20. Fuzik M, Prysyazhnyuk A, Shibata Y, et al. Thyroid cancer incidence in Ukraine: trends with reference to the Chernobyl accident. Radiat Environ Biophys 2010. Go to original source...
  21. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-132. Go to original source... Go to PubMed...
  22. Meier CA. Thyroid nodules: pathogenesis, diagnosis and treatment. Baillieres Best Pract Res Clin Endocrinol Metab 2000; 14: 559-575. Go to original source... Go to PubMed...
  23. Hahm JR, Lee MS, Min YK, et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001; 11: 73-80. Go to original source... Go to PubMed...
  24. Kotzmann H, Schmidt A, Scheuba C, et al. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid 1999; 9: 943-947. Go to original source... Go to PubMed...
  25. Vlaeminck-Guillem V, D'herbomez M, Pigny P, et al. Pseudohypoparathyroidism Ia and hypercalcitoninemia. J Clin Endocrinol Metab 2001; 86: 3091-3096. Go to original source... Go to PubMed...
  26. Erdogan MF, Gullu S, Baskal N, et al. Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 1997; 82: 897-899. Go to original source... Go to PubMed...
  27. Kaserer K, Scheuba C, Neuhold N, et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 1998; 22: 722-728. Go to original source... Go to PubMed...
  28. Gibelin H, Essique D, Jones C, et al. Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 2005; 92: 574-578. Go to original source... Go to PubMed...
  29. Niccoli P, Wion-Barbot N, Caron P, et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 1997; 82: 338-341. Go to original source... Go to PubMed...
  30. Costante G, Filetti S. Early Diagnosis of Medullary Thyroid Carcinoma: Is Systematic Calcitonin Screening Appropriate in Patients with Nodular Thyroid Disease? Oncologist 2011. Go to original source...
  31. Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive Summary of recommendations. J Endocrinol Invest 2010; 33: 287-291. Go to original source... Go to PubMed...
  32. Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000; 133: 696-700. Go to original source... Go to PubMed...
  33. Wiest PW, Hartshorne MF, Inskip PD, et al. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med 1998; 17: 487-496. Go to original source... Go to PubMed...
  34. Asanuma K, Kobayashi S, Shingu K, et al. The rate of tumour growth does not distinguish between malignant and benign thyroid nodules. Eur J Surg 2001; 167: 102-105. Go to original source... Go to PubMed...
  35. Rago T, Vitti P. Potential value of elastosonography in the diagnosis of malignancy in thyroid nodules. Q J Nucl Med Mol Imaging 2009; 53: 455-464. Go to PubMed...
  36. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-559. Go to original source... Go to PubMed...
  37. Schlogl S, Werner E, Lassmann M, et al. The use of threedimensional ultrasound for thyroid volumetry. Thyroid 2001; 11: 569-574. Go to original source... Go to PubMed...
  38. Abdel-Razzak M, Christie JH. Thyroid carcinoma in an autonomously functioning nodule. J Clin Med 1979; 20: 1001-1002.
  39. Hoving J, Piers DA, Vermey A, et al. Carcinoma in hyperfunkctioning thyroid nodule in recurrent hyperthyroidism. Eur J Nucl Med 1981; 6: 131-132. Go to original source... Go to PubMed...
  40. Intenzo CM, Park CH, Cohen SN. Thyroid carcinoma presenting as an autonomous thyroid nodule. Clin Nucl Med 1990; 15: 313-314. Go to original source... Go to PubMed...
  41. Harach HR, Sanchez SS, Williams ED. Pathology of the autonomously functioning (hot) thyroid nodule. Ann Diagn Pathol 2002; 6: 10-19. Go to original source... Go to PubMed...
  42. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351: 1764-1771. Go to original source... Go to PubMed...
  43. Hermans R, Bouillon R, Laga K, et al. Estimation of thyroid gland volume by spiral computed tomography. Eur Radiol 1997; 7: 214-216. Go to original source... Go to PubMed...
  44. Nygaard B, Nygaard T, Court-Payen M, et al. Thyroid volume measured by ultrasonography and CT. Acta Radiol 2002; 43: 269-274. Go to original source... Go to PubMed...
  45. Thusoo TK, Gupta U, Kochhar K, et al. Upper airway obstruction in patients with goiter studies by flow volume loops and effect of thyroidectomy. World J Surg 2000; 24: 1570-1572. Go to original source... Go to PubMed...
  46. Ohba K, Nishizawa S, Matsushita A, et al. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodexyglucose positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocr J 2010; 57: 395-401. Go to original source... Go to PubMed...
  47. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130: 941-946. Go to original source... Go to PubMed...
  48. Heston TF, Wahl RL. Molecular imaging in thyroid cancer. Cancer Imaging 2010; 10: 1-7. Go to original source... Go to PubMed...
  49. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87: 1941-1946. Go to original source... Go to PubMed...
  50. MacDonald L, Yazdi HM. Nondiagnostic fine needle aspiration biopsy of the thyroid gland: a diagnostic dilemma. Acta Cytol 1996; 40: 423-428. Go to original source... Go to PubMed...
  51. Schmidt T, Riggs MW, Speights VOJ. Significance of nondiagnostic fine-needle aspiration of the thyroid. South Med J 1997; 90: 1183-1186. Go to original source... Go to PubMed...
  52. McHenry CR, Walfish PG, Rosen IB. Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg 1993; 59: 415-419. Go to PubMed...
  53. Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 2000; 90: 357-363. Go to original source...
  54. Garcia-Pascual L, Barahona MJ, Balsells M, et al. Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular). Endocrine 2010 Go to original source...
  55. Cap J, Ryska A, Rehorkova P, et al. Sensitivity and specificity of the fine needle aspiration biopsy of the thyroid: clinical point of view. Clin Endocrinol (Oxf) 1999; 51: 509-515. Go to original source... Go to PubMed...
  56. La Rosa GL, Belfiore A, Giuffrida D, et al. Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer 1991; 67: 2137-2141. Go to original source...
  57. Greaves TS, Olvera M, Florentine BD, et al. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 2000; 90: 335-341. Go to original source...
  58. Cibas ES, Ali SZ. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 2009; 132: 658-665. Go to original source... Go to PubMed...
  59. Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2010; 134: 450-456. Go to original source... Go to PubMed...
  60. Tyler DS, Winchester DJ, Caraway NP, et al. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 1994; 116: 1054-1060. Go to PubMed...
  61. Taneri F, Tekin E, Salman B, et al. Huerthle cell neoplasms of the thyroid: predicting malignant potential. Endocr Regul 2000; 34: 19-21. Go to PubMed...
  62. Boelaert K, Horacek J, Holder RL, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006; 91: 4295-4301. Go to original source... Go to PubMed...
  63. Cersosimo E, Gharib H, Suman VJ, et al., ,Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc 1993; 68: 343-348. Go to original source... Go to PubMed...
  64. Schlinkert RT, van Heerden JA, Goellner JR, et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is, ,suspicious for follicular neoplasm". Mayo Clin Proc 1997; 72: 913-916. Go to original source... Go to PubMed...
  65. Ofelia Uribe-Uribe N, Penelope Romero-Lagarza A, Nuncio-Zamora F, et al. [Comparison of the usefulness of intraoperative examination and fine needle aspiration biopsy in thyroid lesions. Analysis of discordant cases in aspiration biopsy]. Rev Invest Clin 2000; 52: 383-390.
  66. Udelsman R, Westra WH, Donovan PI, et al. Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 2001; 233: 716-722. Go to original source... Go to PubMed...
  67. Gabalec F, Cap J, Ryska A, et al. Benign fine-needle aspiration cytology of thyroid nodule: to repeat or not to repeat? Eur J Endocrinol 2009; 161: 933-937. Go to original source... Go to PubMed...
  68. Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005; 90: 581-585; discussion 586-587. Go to original source... Go to PubMed...
  69. Nygaard B, Hegedus L, Nielsen KG, et al. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf) 1999; 50: 197-202. Go to original source... Go to PubMed...
  70. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002; 87: 4154-4159. Go to original source... Go to PubMed...
  71. Yousef A, Clark J, Doi SA. Thyroxine suppression therapy for benign, non-functioning solitary thyroid nodules: a quality-effects meta-analysis. Clin Med Res 2010; 8: 150-158. Go to original source... Go to PubMed...
  72. Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998; 83: 780-783. Go to original source... Go to PubMed...
  73. Bennedbaek FN, Hegedus L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003; 88: 5773-5777. Go to original source... Go to PubMed...
  74. Dossing H, Bennedbaek FN, Hegedus L. Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules - a randomised study. Eur J Endocrinol 2005; 152: 341-345. Go to original source... Go to PubMed...
  75. Dossing H, Bennedbaek FN, Bonnema SJ, et al. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol 2007; 157: 95-100. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.